Magnesium and Hydroxychloroquine
Mg - HCQ
- THIS %22mg2%2B%22+OR+magnesium+OR+mgso4+OR+hypomagnes*+OR+hypermagnes*+OR+trpm7
- AND chloroquine+OR+hydroxychloroquine
- NOT
- PubMed: 08/05/20 PMCentral: ----
- search on moremed.org
22987900 2012. Severe primary hypothyroidism presenting with torsades de pointes.
23203174 2012. Syncope in a patient being treated for hepatic and intestinal amoebiasis.
26351590 2015. Novel Therapies for Myocardial Irritability following Extreme Hydroxychloroquine Toxicity.
14342342 1965. SPECTROPHOTOMETRIC STUDIES OF THE INTERACTION OF CHLOROQUINE WITH DEOXYRIBONUCLEIC ACID.
32650197 2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
673850 1978. The inhibition of mitochondrial DNA polymerase gamma from animal cells by intercalating drugs.
14982575 2004. Massive hydroxychloroquine overdose.
6818843 1982. Weak-base induced lysosomal secretion by macrophages: an alternative trigger mechanism that is independent of complement activation.
7977698 1994. Loss of red blood cell glutathione during Mg deficiency: prevention by vitamin E, D-propranolol, and chloroquine.
8460675 1993. Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in a Mg-deficient rat model.
14067478 1963. THE RESPONSE OF HYPERCALCEMIA IN SARCOIDOSIS TO CHLOROQUINE.
2960325 1987. Inhibition of calmodulin stimulation of phosphodiesterase and Ca2+, Mg2+-ATPase activities and shape change of erythrocyte ghosts by chloroquine.
2990487 1985. Inhibition of phosphatidylinositol phosphodiesterase activity in skeletal muscle by metal ions and drugs which block neuromuscular transmission.
4312459 1969. Chloroquine and synthesis of aminoacyl transfer ribonucleic acids. Conformational changes in tryptophanyl and tryptophan transfer ribonucleic acids.
2831987 1988. Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.
4569158 1972. The inhibition in vitro of bacterial DNA polymerases and RNA polymerase by antimalarial 8-aminoquinolines and by chloroquine.
5750458 1968. Comparison of chloroquine binding to DNA, and polyadenylic and polyguanylic acids.
18538567 2008. Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinoline.
16842209 2006. Antiplatelet and antileukocyte effects of cardiovascular, immunomodulatory and chemotherapeutic drugs.
4966073 1966. Chloroquine-mediated conversion of transfer ribonucleic acid of Escherichia coli from an inactive to an active state.
15038247 2004. Treatment with antimalarials adversely affects the oxidative energy metabolism in rat liver mitochondria.
3556432 1987. Control of membrane permeability in animal cells by divalent cations.
7895830 1995. Plasmodium falciparum and Plasmodium berghei: effect of magnesium on the development of parasitemia.
3905702 1985. Effects of chloroquine on the serum complement system.
11103308 2000. Distribution of key ions of chloroquine biotransformation and cholesterol uptake in rat liver.
1359089 1992. Adsorption of paracetamol and chloroquine phosphate by some antacids.
6292443 1982. The effect of magnesium trisilicate and kaolin on the in vivo absorption of chloroquine.
2460697 1988. Inhibition of adsorptive endocytosis and transcytosis in pulmonary microvessels.
7382912 1980. Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents.
10497894 1999. The effect of binding of chlorpromazine and chloroquine to ion transporting ATPases.
5460005 1970. The effect of chloroquine on the enzymatic hydrolysis of nucleic acids.
